Clinical Trial Update: Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. [Phase 3]

View source ↗

Summary

This is a completed Phase 3 trial evaluating whether pioglitazone plus glimepiride slows progression of atherosclerotic disease in people with Type 2 diabetes m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED